{"id":"W2033722427","doi":"10.1016/j.jval.2012.08.304","title":"PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Number Needed to Treat (NNT) Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Number needed to treat; Lenalidomide; Bortezomib; Multiple myeloma; Thalidomide; Refractory (planetary science); Clinical trial; Internal medicine; Oncology; Confidence interval; Relative risk","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01517835,0.001467505,0.008737765,0.001349144,0.0004326154,0.001428967,0.00185051,0.002148193,0.007459768],"category_scores_gemma":[0.01476524,0.0007053451,0.01618567,0.00115297,0.00100159,0.002777125,0.001357983,0.004103387,0.0004498947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001823815,"about_ca_system_score_gemma":0.001251302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001252561,"about_ca_topic_score_gemma":0.002084798,"domain_scores_codex":[0.9840294,0.01269555,0.0007552484,0.0007406691,0.001203089,0.0005761012],"domain_scores_gemma":[0.9830878,0.01339749,0.001591313,0.0006503389,0.000360943,0.0009119494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.89887,0.001006851,0.005906125,0.001987288,0.02736233,0.0001449433,0.0000638368,0.006271447,0.000793953,0.0006698093,0.001147715,0.05577572],"study_design_scores_gemma":[0.3881402,0.2578945,0.06439349,0.001604318,0.1957512,0.001289152,0.0006663444,0.0571967,0.003924732,0.01720714,0.01151256,0.0004196624],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8992006,0.06692731,0.01182145,0.003022579,0.002516607,0.002407424,0.003660402,0.0001919976,0.01025165],"genre_scores_gemma":[0.9869815,0.00472137,0.003380677,0.0009269148,0.0005007684,0.0004907358,0.0007655475,0.0000620401,0.002170506],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01517835,"threshold_uncertainty_score":0.08027178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1081685437329737,"score_gpt":0.3939873439983528,"score_spread":0.2858188002653791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}